A place of plasma substitutes in the treatment of patients with chronic viral hepatitis
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
Objective — to assess the efficacy of plasma substitute (Reosorbilact) in patients with chronic viral hepatitis. Materials and methods. The investigation involved 60 patients with chronic viral hepatitis (CVH), who were divided into 2 groups: 35 patients of the main group received plasma substitute against the background of the basic therapy, and 25 patients of comparison group received only basic therapy. Along with the generally accepted laboratory tests, the special immunological and biochemical tests have been performed. Results. The investigation demonstration good tolerability of the drug and improvement of the immunological indices. The accelerated normalization of immune regulating CD4/CD8 index in patients of the main group (2.03 ± 0.03; p > 0.05) has been revealed, as well as stimulation of the natural infection-resistance factors in the CVH patients. The administration of the plasma substitute in addition to the basic therapy promoted to the significant increase in the liver antitoxic and proteinsynthesizing functions, resulting in more significant reduction in the severity of syndromes of endogenous and infectious toxicosis. Patients’ condition in the main group improved by the 4- 5the day of treatment (at average on the 3.5 ± 0.2 day), whereas in the comparison group this improvement took place by the end of first week. In the number of cases there was no need in the anti-recurrent therapy to avoid the chronic hepatitis exacerbation during one year of the follow-up care, that testified the achievement of the stable clinical and laboratory remission, occurring by 10 — 15 % oftener in the main than in the comparison group. Conclusions. The drug can be considered as a promising agent for the widespread use in the treatment of patients not only with CVH, but also with other diseases of infectious genesis, for the reduction of intoxication, correction of acid-base balance, improvement of microcirculation, as well as for providing of the antiinflammatory, antioxidant and immune corrective effects.
Authors and Affiliations
F. I. Khamrabaeva
Keywords
Related Articles
- EP ID EP574917
- DOI 10.30978/MG-2019-2-29
- Views 96
- Downloads 0
Efficiency and safety of ademetionine in the correction of liver function in patients with steatohepatitis. Results of an open multicenter comparative post-marketing study
Objective — to study the efficacy and safety of the drug ademetionine, lyophilisate for solution for injection in patients with non-alcoholic steatohepatitis (NASH). Materials and methods. The examinations involved 120 p...
State of the hepatobiliary system in boys with hypoandrogenism
Objective — to study the state of hepatobiliary system in boys/youths with delayed puberty. Materials and methods. The study involved 37 boys and youths with hypoandrogenism, aged 13 — 18 years, who were examined in the...
The new possibilities for the treatment of patients with chronic constipation
Objective — to analyze the efficacy of using the herbal drug EasyDo in patients with chronic constipation. Materials and methods. The observations involved 40 patients with chronic constipation, aged 18 to 65 years, who...
The relationship of serum inflammatory markers with metabolic disorders at the non-alcoholic fatty liver disease
Objective — to study the serum levels of proinflammatory markers and determine their role in the formation of metabolic disorders in patients with non-alcoholic fatty liver disease (NAFLD). Materials and methods. Examin...
Irritable bowel syndrome at young age: Salofalk treatment efficacy
Objective — to analyze the effect of granules of mesalazine on the course of IBS in adolescents and young patients. Materials and methods. We observed 58 children in late adolescence from 15 to 18 years old and 120 youn...